ITMCTR2000003091尚未招募1 期
A randomized double-blind placebo-controlled multicenter trial of Bushen Yisui and Ziyin Jiangzhuo (BYZJ) Formula for constipation in Parkinson's disease
Beijing Rehabilitation Hospital, Capital Medical University0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 30 至 80（—）
- 性别
- All
入选标准
- •1. Diagnosed as idiopathic PD according to the 2015 MDS criteria;
- •2. Diagnosed as constipation according to Rome III diagnostic criteria;
- •3. Aged 30 to 80 years;
- •4. Hoehn and Yahr classification 1-4;
- •5. Sign informed consent and be able to insist on completing the entire treatment process.
排除标准
- •1. Patients who do not take medication under the guidance of a professional doctor or cannot take medication regularly;
- •2. Patients with intestinal organic lesions such as intestinal polyps, intestinal tuberculosis, Crohn's disease, tumors and ulcers. etc;
- •3. Secondary constipation caused by uremia, muscular dystrophy, multiple sclerosis, hypothyroidism and other system diseases;
- •4. Patients with severe heart, brain, liver, kidney, blood system diseases, as well as mental disorders or dementia;
- •5. Higher serum creatinine, ALT or AST than twice the normal value;
- •6. According to the judgment of the researcher, patients who are unable to cooperate throughout the research due to drug abuse or poor adherence;
- •7. Participated in other studies in the past 2 weeks or is currently participating in other clinical trials; or has taken other traditional Chinese medicine preparations in the past 3 months;
- •8. Pregnant and lactating women.
研究者
相似试验
进行中（未招募）
1 期
This is an international study to compare the study drug AR-301 with antibiotics versus antibiotics alone in ventilated patients who have a pneumonia caused by S. aureus.MedDRA version: 20.0Level: PTClassification code 10035734Term: Pneumonia staphylococcalSystem Organ Class: 10021881 - Infections and infestationsStaphylococcus aureus pneumoniaEUCTR2017-004339-35-LVAridis Pharmaceuticals, Inc.240
进行中（未招募）
1 期
This is an international study to compare the study drug AR-301 with antibiotics versus antibiotics alone in ventilated patients who have a pneumonia caused by S. aureus.Staphylococcus aureus pneumoniaEUCTR2017-004339-35-EEAridis Pharmaceuticals, Inc.240
进行中（未招募）
1 期
This is an international study to compare the study drug AR-301 with antibiotics versus antibiotics alone in ventilated patients who have a pneumonia caused by S. aureus.MedDRA version: 20.0Level: PTClassification code 10035734Term: Pneumonia staphylococcalSystem Organ Class: 10021881 - Infections and infestationsStaphylococcus aureus pneumoniaEUCTR2017-004339-35-BEAridis Pharmaceuticals, Inc.240
进行中（未招募）
1 期
This is an international study to compare the study drug AR-301 with antibiotics versus antibiotics alone in ventilated patients who have a pneumonia caused by S. aureus.Staphylococcus aureus pneumoniaEUCTR2017-004339-35-FRAridis Pharmaceuticals, Inc.240
进行中（未招募）
1 期
This is an international study to compare the study drug AR-301 with antibiotics versus antibiotics alone in ventilated patients who have a pneumonia caused by S. aureus.MedDRA version: 20.0Level: PTClassification code 10035734Term: Pneumonia staphylococcalSystem Organ Class: 10021881 - Infections and infestationsStaphylococcus aureus pneumoniaEUCTR2017-004339-35-ESAridis Pharmaceuticals, Inc.240